tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

HK:2509 Stock Latest News

Qyuns Therapeutics Launches Share Buyback as Board Deems Stock Undervalued
Company AnnouncementsQyuns Therapeutics Launches Share Buyback as Board Deems Stock Undervalued
21d ago
2509
Qyuns Steps Up IBD Push as Caldera Raises US$112.5 Million and Starts Phase I Trial of Bispecific Antibody
PremiumCompany Announcements
Qyuns Steps Up IBD Push as Caldera Raises US$112.5 Million and Starts Phase I Trial of Bispecific Antibody
1M ago
2509
Qyuns Therapeutics Launches Share Buyback to Address Undervaluation Concerns
PremiumCompany Announcements
Qyuns Therapeutics Launches Share Buyback to Address Undervaluation Concerns
2M ago
2509
Qyuns Therapeutics Out-Licenses QX027N Globally in Deal Worth Up to US$700 Million
PremiumCompany Announcements
Qyuns Therapeutics Out-Licenses QX027N Globally in Deal Worth Up to US$700 Million
2M ago
2509
Qyuns Therapeutics Shareholders Approve Renewal of Caps for Connected Transactions at EGM
PremiumCompany Announcements
Qyuns Therapeutics Shareholders Approve Renewal of Caps for Connected Transactions at EGM
2M ago
2509
Qyuns Therapeutics Advances Global Clinical Trials with Key Approval
PremiumCompany AnnouncementsQyuns Therapeutics Advances Global Clinical Trials with Key Approval
3M ago
2509
Qyuns Therapeutics Announces EGM to Discuss Key Resolutions
Premium
Company Announcements
Qyuns Therapeutics Announces EGM to Discuss Key Resolutions
3M ago
2509
Qyuns Therapeutics Announces EGM and H Shares Register Closure
Premium
Company Announcements
Qyuns Therapeutics Announces EGM and H Shares Register Closure
3M ago
2509
Qyuns Therapeutics’ QX027N Antibody Gains Clinical Trial Approvals
PremiumCompany Announcements
Qyuns Therapeutics’ QX027N Antibody Gains Clinical Trial Approvals
4M ago
2509
Qyuns Therapeutics Renews Annual Caps for QX001S Framework Agreement
PremiumCompany Announcements
Qyuns Therapeutics Renews Annual Caps for QX001S Framework Agreement
4M ago
2509
Qyuns Therapeutics Initiates Share Repurchase to Boost Market Confidence
PremiumCompany Announcements
Qyuns Therapeutics Initiates Share Repurchase to Boost Market Confidence
4M ago
2509
Qyuns Therapeutics Partners with Roche for Global Development of QX031N
PremiumCompany Announcements
Qyuns Therapeutics Partners with Roche for Global Development of QX031N
4M ago
2509
Qyuns Therapeutics Announces Promising Phase III Results for Ankylosing Spondylitis Treatment
PremiumCompany AnnouncementsQyuns Therapeutics Announces Promising Phase III Results for Ankylosing Spondylitis Treatment
4M ago
2509
Qyuns Therapeutics’ Subsidiary Achieves EU QP Certification, Paving Way for Global Expansion
Premium
Company Announcements
Qyuns Therapeutics’ Subsidiary Achieves EU QP Certification, Paving Way for Global Expansion
5M ago
2509
Premium
Company Announcements
Qyuns Therapeutics Completes Successful Placement of New H Shares
6M ago
2509
PremiumCompany Announcements
Qyuns Therapeutics Announces HK$100 Million H Share Placement
6M ago
2509
PremiumCompany Announcements
Qyuns Therapeutics Reports Strong Revenue Growth in H1 2025
7M ago
2509
PremiumCompany Announcements
Qyuns Therapeutics Enhances Governance with New Lead INED Designation
7M ago
2509
PremiumCompany Announcements
Qyuns Therapeutics Advances QX004N to Phase III Trials, Secures Milestone Payment
7M ago
2509
PremiumCompany AnnouncementsQyuns Therapeutics Schedules Board Meeting for Interim Results
7M ago
2509
Premium
Company Announcements
Qyuns Therapeutics Invests in Wealth Management Products to Optimize Idle Funds
8M ago
2509
Premium
Company Announcements
Qyuns Therapeutics Releases Supplemental Financial Details for 2024
8M ago
2509

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >